biomedical computing limited Company Information
Company Number
03148645
Next Accounts
Sep 2025
Industry
Business and domestic software development
Data processing, hosting and related activities
Shareholders
techmomentum holdings limited
Group Structure
View All
Contact
Registered Address
unit 5, watch oak business centre, battle, TN33 0GB
Website
http://bio-medical.co.ukbiomedical computing limited Estimated Valuation
Pomanda estimates the enterprise value of BIOMEDICAL COMPUTING LIMITED at £656.6k based on a Turnover of £864.3k and 0.76x industry multiple (adjusted for size and gross margin).
biomedical computing limited Estimated Valuation
Pomanda estimates the enterprise value of BIOMEDICAL COMPUTING LIMITED at £436.7k based on an EBITDA of £102.2k and a 4.27x industry multiple (adjusted for size and gross margin).
biomedical computing limited Estimated Valuation
Pomanda estimates the enterprise value of BIOMEDICAL COMPUTING LIMITED at £666.4k based on Net Assets of £275.2k and 2.42x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biomedical Computing Limited Overview
Biomedical Computing Limited is a live company located in battle, TN33 0GB with a Companies House number of 03148645. It operates in the business and domestic software development sector, SIC Code 62012. Founded in January 1996, it's largest shareholder is techmomentum holdings limited with a 100% stake. Biomedical Computing Limited is a mature, small sized company, Pomanda has estimated its turnover at £864.3k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biomedical Computing Limited Health Check
Pomanda's financial health check has awarded Biomedical Computing Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
4 Weak
Size
annual sales of £864.3k, make it smaller than the average company (£5.2m)
- Biomedical Computing Limited
£5.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (8%)
- Biomedical Computing Limited
8% - Industry AVG
Production
with a gross margin of 39.3%, this company has a higher cost of product (67.6%)
- Biomedical Computing Limited
67.6% - Industry AVG
Profitability
an operating margin of 11.8% make it more profitable than the average company (4.2%)
- Biomedical Computing Limited
4.2% - Industry AVG
Employees
with 5 employees, this is below the industry average (37)
5 - Biomedical Computing Limited
37 - Industry AVG
Pay Structure
on an average salary of £75k, the company has an equivalent pay structure (£75k)
- Biomedical Computing Limited
£75k - Industry AVG
Efficiency
resulting in sales per employee of £172.9k, this is more efficient (£142.8k)
- Biomedical Computing Limited
£142.8k - Industry AVG
Debtor Days
it gets paid by customers after 144 days, this is later than average (55 days)
- Biomedical Computing Limited
55 days - Industry AVG
Creditor Days
its suppliers are paid after 57 days, this is slower than average (39 days)
- Biomedical Computing Limited
39 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biomedical Computing Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Biomedical Computing Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 23.1%, this is a lower level of debt than the average (58.2%)
23.1% - Biomedical Computing Limited
58.2% - Industry AVG
BIOMEDICAL COMPUTING LIMITED financials
Biomedical Computing Limited's latest turnover from December 2023 is estimated at £864.3 thousand and the company has net assets of £275.2 thousand. According to their latest financial statements, Biomedical Computing Limited has 5 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 5 | 5 | 5 | 5 | 5 | 6 | 5 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,589 | 2,296 | 2,077 | 1,567 | 449 | 728 | 727 | 316 | 634 | 1,079 | 642 | 1,784 | 3,387 | 4,977 | 5,463 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80 | 114 | 34 | 34 | 1 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,589 | 2,296 | 2,077 | 1,567 | 449 | 728 | 727 | 316 | 634 | 1,079 | 722 | 1,898 | 3,421 | 5,011 | 5,464 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,684 | 2,149 | 2,149 | 0 | 0 | 0 | 0 |
Trade Debtors | 341,137 | 272,575 | 253,344 | 224,536 | 217,260 | 234,777 | 202,948 | 178,595 | 79,919 | 79,297 | 62,661 | 64,206 | 52,831 | 48,378 | 35,646 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 15,072 | 14,996 | 35,739 | 19,767 | 38,296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 112,550 | 86,620 | 84,260 | 91,702 | 106,915 | 92,168 | 99,681 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 8,254 | 16,777 | 20,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 356,209 | 287,571 | 289,083 | 244,303 | 255,556 | 243,031 | 219,725 | 198,595 | 194,153 | 168,066 | 149,070 | 155,908 | 159,746 | 140,546 | 135,327 |
total assets | 357,798 | 289,867 | 291,160 | 245,870 | 256,005 | 243,759 | 220,452 | 198,911 | 194,787 | 169,145 | 149,792 | 157,806 | 163,167 | 145,557 | 140,791 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 82,551 | 91,235 | 93,214 | 74,292 | 67,083 | 57,079 | 58,600 | 46,954 | 54,336 | 51,614 | 46,894 | 49,469 | 44,661 | 37,387 | 33,078 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 82,551 | 91,235 | 93,214 | 74,292 | 67,083 | 57,079 | 58,600 | 46,954 | 54,336 | 51,614 | 46,894 | 49,469 | 44,661 | 37,387 | 33,078 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 82,551 | 91,235 | 93,214 | 74,292 | 67,083 | 57,079 | 58,600 | 46,954 | 54,336 | 51,614 | 46,894 | 49,469 | 44,661 | 37,387 | 33,078 |
net assets | 275,247 | 198,632 | 197,946 | 171,578 | 188,922 | 186,680 | 161,852 | 151,957 | 140,451 | 117,531 | 102,898 | 108,337 | 118,506 | 108,170 | 107,713 |
total shareholders funds | 275,247 | 198,632 | 197,946 | 171,578 | 188,922 | 186,680 | 161,852 | 151,957 | 140,451 | 117,531 | 102,898 | 108,337 | 118,506 | 108,170 | 107,713 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 446 | 832 | 1,141 | 2,114 | 3,137 | 2,995 | 2,394 | ||||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,684 | -465 | 0 | 2,149 | 0 | 0 | 0 | 0 |
Debtors | 68,638 | -1,512 | 44,780 | -11,253 | 20,779 | 31,829 | 24,353 | 98,676 | 622 | 16,636 | -1,545 | 11,375 | 4,453 | 12,732 | 35,646 |
Creditors | -8,684 | -1,979 | 18,922 | 7,209 | 10,004 | -1,521 | 11,646 | -7,382 | 2,722 | 4,720 | -2,575 | 4,808 | 7,274 | 4,309 | 33,078 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -80 | -34 | 80 | 0 | 33 | 1 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -112,550 | 25,930 | 2,360 | -7,442 | -15,213 | 14,747 | -7,513 | 99,681 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -112,550 | 25,930 | 2,360 | -7,442 | -15,213 | 14,747 | -7,513 | 99,681 |
biomedical computing limited Credit Report and Business Information
Biomedical Computing Limited Competitor Analysis
Perform a competitor analysis for biomedical computing limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in TN33 area or any other competitors across 12 key performance metrics.
biomedical computing limited Ownership
BIOMEDICAL COMPUTING LIMITED group structure
Biomedical Computing Limited has no subsidiary companies.
Ultimate parent company
BIOMEDICAL COMPUTING LIMITED
03148645
biomedical computing limited directors
Biomedical Computing Limited currently has 4 directors. The longest serving directors include Dr James Densem (Jan 1996) and Mr Nicholas Sellick (May 2005).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr James Densem | England | 70 years | Jan 1996 | - | Director |
Mr Nicholas Sellick | England | 58 years | May 2005 | - | Director |
Mr Simon Mumford | England | 44 years | Jan 2024 | - | Director |
Mr Adrian Davis | England | 43 years | Jan 2024 | - | Director |
P&L
December 2023turnover
864.3k
+26%
operating profit
102.2k
0%
gross margin
39.4%
+6.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
275.2k
+0.39%
total assets
357.8k
+0.23%
cash
0
0%
net assets
Total assets minus all liabilities
biomedical computing limited company details
company number
03148645
Type
Private limited with Share Capital
industry
62012 - Business and domestic software development
63110 - Data processing, hosting and related activities
incorporation date
January 1996
age
28
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
unit 5, watch oak business centre, battle, TN33 0GB
Bank
-
Legal Advisor
-
biomedical computing limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to biomedical computing limited. Currently there are 1 open charges and 0 have been satisfied in the past.
biomedical computing limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOMEDICAL COMPUTING LIMITED. This can take several minutes, an email will notify you when this has completed.
biomedical computing limited Companies House Filings - See Documents
date | description | view/download |
---|